Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Silo Pharma (SILO) Net Margin (2016 - 2025)

Historic Net Margin for Silo Pharma (SILO) over the last 11 years, with Q3 2025 value amounting to 6160.54%.

  • Silo Pharma's Net Margin fell 10076200.0% to 6160.54% in Q3 2025 from the same period last year, while for Sep 2025 it was 7041.12%, marking a year-over-year decrease of 18903100.0%. This contributed to the annual value of 6092.59% for FY2024, which is 59960600.0% down from last year.
  • As of Q3 2025, Silo Pharma's Net Margin stood at 6160.54%, which was down 10076200.0% from 6681.24% recorded in Q2 2025.
  • In the past 5 years, Silo Pharma's Net Margin registered a high of 509340.85% during Q4 2021, and its lowest value of 1321970.81% during Q3 2021.
  • In the last 5 years, Silo Pharma's Net Margin had a median value of 5454.9% in 2022 and averaged 47651.07%.
  • Per our database at Business Quant, Silo Pharma's Net Margin tumbled by 2000000000bps in 2021 and then surged by 2000000000bps in 2022.
  • Silo Pharma's Net Margin (Quarter) stood at 509340.85% in 2021, then crashed by -102bps to 9224.63% in 2022, then surged by 37bps to 5833.66% in 2023, then tumbled by -65bps to 9600.69% in 2024, then skyrocketed by 36bps to 6160.54% in 2025.
  • Its Net Margin was 6160.54% in Q3 2025, compared to 6681.24% in Q2 2025 and 5721.94% in Q1 2025.